Table 1.
Characteristics | n (%) |
---|---|
Total of patients | 101 (100) |
Age (m ± SD) | 35.5 ± 13.3 |
Age group years | |
<=40 | 64 (63.4) |
>40 | 37 (36.6) |
Gender | |
Male/female | 72/29 (71.3/28.7) |
Residence | |
Urban/rural | 80/21 (79.2/20.8) |
Employment | |
Unemployed | 50 (49.5) |
Employed | 24 (23.8) |
Not available | 27 (26.7) |
Marital status | |
Single/married | 41/45 (40.6/44.5) |
Not available | 15 (14.8) |
Previous TB history | 84 (83.2) |
Characteristics | n (%) |
PTB+ at baseline | 82 (81.2) |
Smoking habits | 32 (31.7) |
Comorbidity | 20 (19.8) |
Culture positivity during intensive phase TB drug resistance types |
46 (45.5) |
MDR | 74 (73.3) |
INH + RIF | 41 (40.6) |
INH + RIF + STP | 17 (16.8) |
INH + RIF + STP + MTB | 9 (8.9) |
INH + RIF + MTB | 4 (4) |
INH + RIF + MTB + STP + Ofx | 1 (1) |
INH + RIF + STP + PZA | 1 (1) |
INH + RIF + Eto + Km | 1 (1) |
Rifampicin resistance | 25 (24.7) |
Isoniazid resistance | 2 (2) |
ADR | 49 (48.5) |
m mean, SD standard deviation, TB tuberculosis, PTB+ smear positive pulmonary tuberculosis, MDR multidrug-resistant tuberculosis, INH Isoniazid, RIF Rifampicin, PZA Pyrazinamid, MTB Ethambutol, STP Streptomycin, Ofx Ofloxacin; Eto: Ethionamide, Km Kanamycin, ADR adverse reactions